Score Overview
Explore the 2021 public Archive ranking β
Where Nephros Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- NEPH
2010: 16.9% Β· 2021: 79.7% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 3.89 | β |
1 Year2025-09-29 | $ 4.57 | -14.88% |
5 Years2021-09-29 | $ 8.45 | -53.96% |
10 Years2016-09-29 | $ 2.88 | 35.07% |
20 Years2006-09-29 | $ 180.00 | -97.84% |
All Time2004-09-21 | $ 1.05K | -99.63% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | All Time2004-09-21 |
|---|---|---|---|---|---|---|
| Price | $ 3.89 | $ 4.57 | $ 8.45 | $ 2.88 | $ 180.00 | $ 1.05K |
| Return | β | -14.88% | -53.96% | 35.07% | -97.84% | -99.63% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 20M | $ 1M | $ 4M |
| 2025 | $ 18M | $ 1M | $ 5M |
| 2024 | $ 14M | $ 74K | $ 3M |
| 2023 | $ 14M | -$ 1M | $ 4M |
| 2022 | $ 9M | -$ 7M | $ 3M |
| 2021 | $ 10M | -$ 4M | $ 6M |
| 2020 | $ 8M | -$ 4M | $ 8M |
| 2019 | $ 10M | -$ 3M | $ 4M |
| 2018 | $ 5M | -$ 3M | $ 4M |
| 2017 | $ 3M | -$ 809K | $ 2M |
| 2016 | $ 2M | -$ 3M | $ 302K |
| 2015 | $ 1M | -$ 3M | $ 1M |
| 2014 | $ 1M | -$ 7M | $ 1M |
| 2013 | $ 1M | -$ 3M | $ 579K |
| 2012 | $ 1M | -$ 3M | $ 47K |
| 2011 | $ 2M | -$ 2M | $ 1M |
| 2010 | $ 2M | -$ 1M | $ 240K |
| 2009 | $ 2M | -$ 2M | $ 1M |
| 2008 | $ 1M | -$ 6M | $ 2M |
| 2007 | $ 1M | -$ 26M | $ 8M |
| 2006 | $ 793.49K | -$ 8M | $ 3M |
| 2005 | $ 2M | -$ 5M | $ 5M |
| IPO2004 | $ 138.41K | -$ 7M | $ 9M |

Nephros Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 8M to $ 18M and net income went from -$ 4M to $ 1M. Revenue increased in 3 of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from $ 1M to $ 18M and net income went from -$ 3M to $ 1M. Revenue increased in 7 of those 10 years; net income in 6.
Nephros Inc currently holds a 20-year HDB Score of 4.6 out of 10. How the HDB Score is calculated.
Membership
Continue NEPHβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio




